首页> 外文期刊>Regulatory peptides. >Chronic intraparaventricular nuclear administration of orexin A in male rats does not alter thyroid axis or uncoupling protein-1 in brown adipose tissue.
【24h】

Chronic intraparaventricular nuclear administration of orexin A in male rats does not alter thyroid axis or uncoupling protein-1 in brown adipose tissue.

机译:在雄性大鼠中长期进行脑室内orexin A核给药不会改变棕色脂肪组织中的甲状腺轴或解偶联蛋白1。

获取原文
获取原文并翻译 | 示例
           

摘要

Orexin A, synthesised in the posterolateral hypothalamus, has widespread distribution including the paraventricular nucleus (PVN), which is rich in thyrotropin-releasing hormone (TRH) neurones. Nerve fibres in the PVN synapse on neurones that send polysynaptic projections to brown adipose tissue (BAT), which is important in thermogenesis. A number of observations suggests orexin A may be involved in regulation of metabolism and thermogenesis. We investigated the effect of orexin A injected intracerebroventricularly (ICV) on thyroid-stimulating hormone (TSH) and thyroid hormones in male rats. We then examined the effect of chronic iPVN injections of orexin A on plasma TSH and uncoupling protein-1 (UCP-1) protein in BAT. Orexin A (3 nmol) administered ICV significantly suppressed plasma TSH at 10 and 90 min. Orexin A (0.3 nmol) administered into the PVN twice daily for 3 days significantly increased day-time 2-h food intake, but did not significantly alter nocturnal food intake. Though chronic iPVN orexin A altered diurnal food intake, there was no effect on 24-h food intake or body weight. Furthermore, orexin A administered chronically into the PVN did not alter UCP-1 level in BAT, or plasma hormones relative to saline injected animals. Chronic iPVN orexin A does not appear to influence thermogenesis through activation of UCP-1 or the thyroid axis.
机译:在后外侧下丘脑中合成的食欲素A具有广泛的分布,包括室旁核(PVN),其富含促甲状腺激素释放激素(TRH)神经元。 PVN突触神经元上的神经纤维将多突触投射物发送到棕色脂肪组织(BAT),这在生热中很重要。许多观察结果表明,食欲素A可能参与了代谢和生热的调节。我们调查了脑室内注射食欲肽A(ICV)对雄性大鼠甲状腺刺激激素(TSH)和甲状腺激素的影响。然后,我们检查了orexin A的慢性iPVN注射对BAT中血浆TSH和解偶联蛋白1(UCP-1)蛋白的影响。 Orexin A(3 nmol)给予ICV在10和90分钟时可显着抑制血浆TSH。每天两次在PVN中连续3天服用Orexin A(0.3 nmol),可以显着增加日间2小时的食物摄入量,但不会显着改变夜间食物摄入量。尽管慢性iPVN食欲素A改变了每日食物摄入量,但对24小时食物摄入量或体重没有影响。此外,相对于注射生理盐水的动物,长期向PVN中施用的orexin A不会改变BAT中的UCP-1水平或血浆激素水平。慢性iPVN食欲素A似乎不通过激活UCP-1或甲状腺轴来影响产热。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号